| 61 |
Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
|
2019 |
| 62 |
Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia |
2019 |
| 63 |
Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia |
2019 |
| 64 |
Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia |
2019 |
| 65 |
Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
|
2019 |
| 66 |
Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
|
2019 |
| 67 |
Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
|
2019 |
| 68 |
Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome |
2019 |
| 69 |
Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome. |
2019 |
| 70 |
Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute |
2019 |
